Download by
Scanning QR Code
No Stock Yet
Lifecome Biochemistry Resumes Factory Operations
02:08 AM EST, 02/07/2023 (MT Newswires) -- Lifecome Biochemistry (SHE:002868) resumed operations at its Putan veterinary drug factory yesterday. The Chinese biopharmaceutical company temporarily suspe
The opening of the POE film sector is active, Maohua Shihua Lianglian
The photovoltaic sector continues to rise and lead the way in the direction of auxiliary materials
A-share review: The Shanghai Index fluctuated narrowly to adjust the transaction amount of the two markets to fall below 600 billion
Lifecome Biochemistry Nixes Plan to Buy New Materials, Thermal Energy Firms
08:23 PM EDT, 08/07/2022 (MT Newswires) -- Lifecome Biochemistry (SHE:002868) cancelled its plan to buy the entire equity stakes in two companies, it said Monday. The Chinese pharmaceutical company ha
Lukang biochemical (002868.SZ): "Putan Industrial Park cogeneration project" unit start-up and grid-connected trial operation
Zhitong Financial APP News, Lukang biochemical (002868.SZ) notice, the company with its own funds to invest in the construction of the "Putan Industrial Park cogeneration project" ("cogeneration project") recently entered the unit start-up and grid trial operation stage. It is reported that the cogeneration project is located in Putan Industrial Park, Pucheng County, with the construction of two 90t/h high-temperature and high-pressure circulating fluidized bed boilers and one 12MW coal-fired back pressure unit, as well as simultaneous construction of desulphurization, denitrification, dust removal equipment and supporting facilities.
002868.SZ has obtained "Veterinary Drug GMP Certificate" and "Veterinary Drug production license".
Zhitong Financial APP News, Lukang biochemical (002868.SZ) issued a notice that the company recently received the people's Republic of China "Veterinary Drug GMP Certificate" and "Veterinary Drug production license" issued by the Agricultural and Rural Department of Fujian Province. The Code for quality Management of Veterinary Drug production (revised in 2020) (referred to as "the new version of Veterinary Drug GMP") was issued on April 21, 2020 and will enter into force on June 1, 2020. The new version of veterinary drug GMP has more stringent requirements on the hardware and software of veterinary drug production, and requires to meet the requirements of the new version of veterinary drug GMP by June 1, 2022. According to the new version of veterinary drug GMP
Lukang biochemical (002868.SZ): director Lai Jianping intends to reduce his holdings of no more than 57900 shares
002868.SZ announced that director Lai Jianping directly holds 231660 shares of the company (accounting for 0.15% of the company's total share capital) and plans to reduce no more than 57915 shares of the company through centralized bidding (except for the period during which the reduction is prohibited according to relevant laws and regulations) within 6 months after the announcement of the reduction plan. That is, not more than 0.04% of the total share capital of the company.
Lai Jianping, director of 002868.SZ, intends to reduce his holdings of no more than 57900 shares.
Zhitong Financial APP News, Lukang biochemical (002868.SZ) announcement, company director Lai Jianping intends to reduce the company's shares, is expected to reduce no more than 57900 shares.
Lukang biochemical (002868.SZ): net loss of 8.9138 million yuan in the first quarter
002868.SZ released its report for the first quarter of 2022 on April 14. During the reporting period, the company realized operating income of 62.6871 million yuan, down 31.06% from the same period last year. The net profit belonging to shareholders of listed companies was-8.9138 million yuan, turning losses into profits compared with the same period last year. Net profits belonging to shareholders of listed companies after deducting non-recurring gains and losses were-4.9516 million yuan; and basic earnings per share were-0.06 yuan.
Loading...
No Stock Yet